Renal Pelvis Neoplasms Active Not Recruiting Phase 1 / 2 Trials for Enfortumab vedotin (DB13007)

IndicationStatusPhase
DBCOND0091608 (Renal Pelvis Neoplasms)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03288545A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial CancerTreatment